News
An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...
A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...
A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...
The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...
The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...
The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...
A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...
A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...
With allergy season in full swing, Dr. Purvi Parikh joins Saturday TODAY to break down why many may be experiencing worse ...
Decongestant sprays shouldn't be used for more than a week - but those who don't realise can become trapped in a cycle of ...
Indivior PLC’s recovery hinges on Sublocade’s momentum and market trends, though risks persist in litigation and earnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results